Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-08-29
2009-02-24
Goldberg, Jeanine A (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C536S023100, C536S024300
Reexamination Certificate
active
07494777
ABSTRACT:
The invention concerns the genomic sequence of the FLAP gene. The invention also concerns biallelic markers of a FLAP gene and the association established between these markers and diseases involving the leukotriene pathway such as asthma. The invention provides means to determine the predisposition of individuals to diseases involving the leukotriene pathway as well as means for the diagnosis of such diseases and for the prognosis/detection of an eventual treatment response to agents acting on the leukotriene pathway.
REFERENCES:
patent: 5182367 (1993-01-01), Gillard et al.
patent: 5578443 (1996-11-01), Santamaria et al.
patent: 5702890 (1997-12-01), Housman
patent: 6531279 (2003-03-01), Blumenfeld et al.
patent: 2032253 (1991-06-01), None
patent: WO 95/35372 (1995-12-01), None
patent: WO 97/42347 (1997-11-01), None
In, K. H. et al. “Naturally Occurring Mutations in the Human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription”,J. Clin. Invest., Mar. 1997, pp. 1130-1137, vol. 99, No. 5.
Morgan, L. et al. “DNA Polymorphisms and Linkage Disequilibrium in the Angiotensinogen Gene”,Human Genet., 1996, pp. 194-198, vol. 98.
Daniels, S. E. et al. “A Genome-Wide Search for Quantitative Trait Loci Underlying Asthma”,Nature, 1996, pp. 247-250, vol. 383.
Dixon, R. A. F. et al. “Requirement of a 5-Lipoxygenase-Activating Protein for Leukotriene Synthesis”,Nature, 1990, pp. 282-284, vol. 343.
Fan, J. et al. “Genetic Mapping: Finding and Analyzing Single-Nucleotide Polymorphisms with High-Density DNA arrays”,American Journal of Human Genetics, 1997, p. 1601, vol. 61, No. 4.
Greally, M. et al. “The Genetics of Asthma”,Irish Medical Journal, 1982, pp. 403-405, vol. 75, No. 11.
Hoshiko, S. et al. “Characterization of the Human 5-Lipoxygenase Gene Promoter”,Proc. Natl. Acad. Sci., 1990, pp. 9073-9077, vol. 87.
Kennedy, B. P. et al. “Gene Characterization and Promoter Analysis of the Human 5-Lipoxygenase Activating Protein (FLAP)”,The Journal of Biological Chemistry, 1991, pp. 8511-8516, vol. 266, No. 13.
Kruglyak, L. “The Use of a Genetic Map of Biallelic Markers in Linkage Studies”,Nature Genetics, 1997, pp. 21-24, vol. 17.
Mancini, et al. “The Binding of Leukotriene Biosynthesis Inhibitors to Site-Directed Mutants of Human 5-Lipoxygenase-Activating Protein”,Life Sciences, 1994, pp. 137-142, vol. 54, No. 9.
Nicolaides, N. C. et al. “Interleukin 9: A Candidate Gene for Asthma”,Proc. Natl. Acad. Sci., 1997, pp. 13175-13180, vol. 94.
Noguchi, E. et al. “Evidence for Linkage Between Asthma/atopy in Childhood and Chromosome 5q31-q33 in a Japanese Population”,Am. J. Respir. Crit. Care Med., 1997, pp. 1390-1393, vol. 156.
Reid, G. K. et al. “Correlation Between Expression of 5-Lipoxygenase-Activating Protein, 5-Lipoxygenase, and Cellular Leukotriene Synthesis”,The Journal of Biological Chemistry, 1990, pp. 19818-19823, vol. 265, No. 32.
Schork, T. et al. “Linkage Disequilibrium Mapping for Quantitative Traits Within Case/Control Settings”,American Journal of Human Genetics, 1997, p. A283, vol. 61, No. 4.
Syvanen, A. C. et al. “Identification of Individuals by Analysis of Biallelic DNA Markers, Using PCR and Solid-Phase Minisequencing”,Am. J. Hum. Genet., 1993, pp. 46-59, vol. 52.
Thomas, N. S. et al. “The Candidate Region Approach to the Genetics of Asthma and Allergy”,Am. J. Respir. Crit. Care Med., 1997, pp. S144-S151, vol. 156.
Thomas, N. S. et al. “Candidate Locus Approach for Studying the Genetics of Asthma and Atopy”,Monaldi Arch Chest Dis, 1997, pp. 296-302, vol. 52, No. 3.
Vickers, P. et al. “Cross-Species Comparison of 5-Lipoxygenase-Activating Protein”,Molecular Pharmacology, 1992, pp. 1014-1019, vol. 42.
Kedda, M.-A. et al. “Polymorphisms in the 5-Lipoxygenase Activating Protein (AL0X5ZP) Gene are Not Associated with Asthma in an Australian Population”,Clin. Exp. Allergy, Mar. 2005, pp. 332-338, vol. 35.
Vickers, P. et al. “Amino Acid Residues of 5-Lipoxygenase-Activating Protein Critical for the Binding of Leukotriene Biosynthesis Inhibitors”,Journal of Lipid Mediators, 1993, pp. 31-42, vol. 6.
Vickers, P. “5-Lipoxygenase-Activating Protein (FLAP)”,J. Lipid Mediators Cell Signaling, 1995, pp. 185-194, vol. 12.
Voelkel, N. F. et al. “Inhibition of 5-Lipoxygenase-Activating Protein (FLAP) Reduces Pulmonary Vascular Reactivity and Pulmonary Hypertension in Hypoxic Rats”,J. Clin. Invest., 1996, pp. 2491-2498, vol. 97, No. 11.
Wang, et al. “Toward a Third Generation Genetic Map of the Human Genome Based on Bi-allelic Polymorphims”,American Journal of Human Genetics, 1990, p. A03, vol. 59, No. 4.
Genbank X52195, Nov. 26, 1992.
Genbank M63262, Mar. 15, 1991.
Genbank M63261, Mar. 15, 1991.
Genbank M63260, Mar. 15, 1991.
Genbank M63259, Mar. 15, 1991.
Genbank M60470, Mar. 15, 1991.
EMBL, AA355068.1, Apr. 18, 1997.
Devlin, B. et al. “A Comparison of Linkage Disequilibrium Measures for Fine-Scale Mapping”Genomics, 1995, pp. 311-322, vol. 29.
Jorde, L. B. “Invited Editorial: Linkage Disequilibrium as a Gene-Mapping Tool”American Journal of Human Genetics, 1995, pp. 11-14, vol. 56.
Laan, M. et al. “Demographic history and linkage disequilibrium in human populations”Nature Genetics, Dec. 1997, pp. 435-438, vol. 17.
Morris, A. P. et al. “A likelihood ratio test for detecting patterns of disease-marker association”Annual Human Genetics, 1997, pp. 335-350, vol. 61.
Risch, N. et al. “The Future of Genetic Studies of Complex Human Diseases”Science, Sep. 13, 1996, pp. 1516-1517, vol. 273, No. 5281.
Wang, D. et al. “Large-Scale Identification, Mapping, and Genotyping of Single-Nucleotide Polymorphisms in the Human Genome”Science, May 15, 1998, pp. 1077-1082, vol. 280.
Ford-Hutchinson, A. W. “Regulation of leukotriene biosynthesis”,Cancer Metastasis Rev., Dec. 1994, pp. 257-267, vol. 13, Nos. 3-4, abstract only.
Blumenfeld Marta
Bougueleret Lydie
Chumakov Ilya
Goldberg Jeanine A
Saliwanchik Lloyd & Saliwanchik
Serono Genetics Institute S.A.
LandOfFree
Genomic sequence of the 5-lipoxygenase-activating protein... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genomic sequence of the 5-lipoxygenase-activating protein..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genomic sequence of the 5-lipoxygenase-activating protein... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4122966